Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
2
×
boston top stories
clinical trials
2
×
deals
fda
life sciences
national blog main
national top stories
roche
alexion pharmaceuticals
alnylam pharmaceuticals
avapritinib
blueprint medicines
boehringer ingelheim
cstone pharmaceuticals
dicerna pharamceuticals
eli lilly
european medicines agency
fisogatinib
flatiron health
genentech
hepatitis b
hepatitis b virus
hepatocellular carcinoma
hereditary transthyretin amyloidosis
investing
jeff albers
medullary thyroid cancer
non-small cell lung cancer
patisiran
pralsetinib
rna interference
san francisco blog main
san francisco top stories
selpercatinib
thermo fisher scientific
thyroid cancer
world health organization
What
drug
medicines
roche
team
2
×
approval
blueprint
cancer
candidate
caught
causing
currently
dicerna
disease
eye
fda
gene
hepatitis
intended
marketing
muscle
pact
pay
pharma
pharmaceuticals
producing
protein
regulatory
research
ret
review
stop
wins
Language
unset
Current search:
team
×
" clinical trials "
×
" boston blog main "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug